Get your non-viral T cell engineering process ready for clinical manufacturing

Watch the video or view the poster to learn about: How to close and automate your T cell electroporation protocol to get it ready for clinical manufacturing       How complex gene modifications are enabled by the combination of electroporation and transduction How to tackle challenges during process development and translation into clinical manufacturing

Melanie Rietenbach is a Global Product Manager and Group Leader for the Immunotherapy portfolio at Miltenyi Biotec. During the last 4 years, she has been working together with the R&D and Clinical Development Team in order to advance the development of tools to enable engineered T cell immunotherapy. Before that, Melanie already supported Miltenyi Biotec in her role as Application Development Specialist and Clinical Product Specialist for more than 3 years. During that time, she was responsible for technical support and application training on Miltenyi Biotec’s clinical product portfolio with focus on cell and gene therapy applications and related products.

Please enter your email to access content Read now